CAMP Continuation Study/Phase 2

此申请表是否供哈佛先锋医学协会(HVMA)参加 儿童哮喘管理方案继续研究/第二阶段(CAMPCS/2)。 CAMPCS/2的摘要和研究p_a0包含在华盛顿大学的申请书中(Robert Strunk，Pi)。 这个HVMA诊所致力于参与CAMPCS/2，并支持对CAMP患者的持续跟踪。我们将继续收集高质量的数据。我们在cAMP中招募了124名患者，在CAMPCS中招募了115名患者。CAMPCS的家属和患者继续致力于这项研究，我们期待他们通过CAMPCS/2继续参与。我们已经成功地将94%的原始营地队列招募到CAMPCS，我们将继续为CAMPCS/2招募原始营地队列。CAMPCS的参与一直很好，94-97%的患者完成了CAMPCS的研究访问，完成窗口已经关闭。

This application if for the Harvard Vanguard Medical Associates (HVMA) to participate in the Childhood Asthma Management Program Continuation Study/Phase 2 (CAMPCS/2). The abstract and, research p_a0 for CAMPCS/2 are included in the application for the Washington University (Robert Strunk, PI). This HVMA clinic is committed to participating in CAMPCS/2 and supports the continued follow up of CAMP patients. We will continue to collect data of high quality. We enrolled 124 patients in CAMP and enrolled 115 patients in CAMPCS. The families and patients of CAMPCS continue to be committed to the study and we anticipate their continued involvement through CAMPCS/2. We have successfully recruited 94% of the original CAMP cohort into CAMPCS, and we will continue to recruit the original CAMP cohort for CAMPCS/2. Participation in CAMPCS has been excellent with 94-97% of patients completing CAMPCS study visits for which the completion window has closed.